Background: Numerous currently incurable human diseases have been causally linked to mutations in connexin (Cx) genes. In several instances, pathological mutations generate abnormally active Cx hemichannels, referred to also as “leaky” hemichannels. The goal of this study was to assay the in vivo efficacy of a potent antagonist antibody targeting Cx hemichannels. Methods: We employed the antibody to treat Cx3
A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice
Ziraldo Gaia;Peres Chiara;Nardin Chiara;Salvatore Anna Maria;Chiani Francesco;Scavizzi Ferdinando;Raspa Marcello;Mammano Fabio
2020
Abstract
Background: Numerous currently incurable human diseases have been causally linked to mutations in connexin (Cx) genes. In several instances, pathological mutations generate abnormally active Cx hemichannels, referred to also as “leaky” hemichannels. The goal of this study was to assay the in vivo efficacy of a potent antagonist antibody targeting Cx hemichannels. Methods: We employed the antibody to treat Cx3File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
main (1).pdf
accesso aperto
Licenza:
Creative commons
Dimensione
3.6 MB
Formato
Adobe PDF
|
3.6 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.